GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Aroa Biosurgery Ltd (ASX:ARX) » Definitions » Price-to-Free-Cash-Flow

Aroa Biosurgery (ASX:ARX) Price-to-Free-Cash-Flow : N/A (As of Jun. 01, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Aroa Biosurgery Price-to-Free-Cash-Flow?

As of today (2024-06-01), Aroa Biosurgery's share price is A$0.57. Aroa Biosurgery's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 was A$-0.04. Hence, Aroa Biosurgery's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Aroa Biosurgery's Price-to-Free-Cash-Flow or its related term are showing as below:

ASX:ARX's Price-to-Free-Cash-Flow is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 34.365
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Aroa Biosurgery's Free Cash Flow per Share for the six months ended in Mar. 2024 was A$-0.01. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was A$-0.04.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was -23.90% per year.

During the past 5 years, Aroa Biosurgery's highest 3-Year average Free Cash Flow per Share Growth Rate was -23.90% per year. The lowest was -23.90% per year. And the median was -23.90% per year.


Aroa Biosurgery Price-to-Free-Cash-Flow Historical Data

The historical data trend for Aroa Biosurgery's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aroa Biosurgery Price-to-Free-Cash-Flow Chart

Aroa Biosurgery Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
Price-to-Free-Cash-Flow
- - - - -

Aroa Biosurgery Semi-Annual Data
Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial - - - - -

Competitive Comparison of Aroa Biosurgery's Price-to-Free-Cash-Flow

For the Medical Devices subindustry, Aroa Biosurgery's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aroa Biosurgery's Price-to-Free-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Aroa Biosurgery's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Aroa Biosurgery's Price-to-Free-Cash-Flow falls into.



Aroa Biosurgery Price-to-Free-Cash-Flow Calculation

Aroa Biosurgery's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.57/-0.038
=N/A

Aroa Biosurgery's Share Price of today is A$0.57.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Aroa Biosurgery's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 was A$-0.04.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Aroa Biosurgery  (ASX:ARX) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Aroa Biosurgery Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Aroa Biosurgery's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Aroa Biosurgery (ASX:ARX) Business Description

Traded in Other Exchanges
N/A
Address
64 Richard Pearse Drive, Mangere, Airport Oaks, Auckland, NZL, 2022
Aroa Biosurgery Ltd is a soft tissue regeneration company which develops, manufactures and sells medical devices for wound and soft tissue repair using its proprietary extracellular matrix (ECM) technology. It is focused on improving the rate and quality of healing in complex wounds and soft tissue reconstruction. The Company is in the business of developing, manufacturing and selling soft tissue repair products. The company's principal market is the United States where it has five key products for sale targeting chronic wounds, hernia, plastics, reconstructive surgery and trauma/limb salvage/tumor surgery.

Aroa Biosurgery (ASX:ARX) Headlines

No Headlines